Page last updated: 2024-10-26

dimaprit and Bone Loss, Osteoclastic

dimaprit has been researched along with Bone Loss, Osteoclastic in 1 studies

Dimaprit: A histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors.

Research Excerpts

ExcerptRelevanceReference
"The effects of cimetidine on rat adjuvant arthritis (AA) and rat osteoclast differentiation were studied."3.72The histamine H2-receptor antagonist, cimetidine, inhibits the articular osteopenia in rats with adjuvant-induced arthritis by suppressing the osteoclast differentiation induced by histamine. ( Nakamura, T; Ueno, K; Yamaura, K; Yano, S; Yonekawa, T, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamaura, K1
Yonekawa, T1
Nakamura, T1
Yano, S1
Ueno, K1

Other Studies

1 other study available for dimaprit and Bone Loss, Osteoclastic

ArticleYear
The histamine H2-receptor antagonist, cimetidine, inhibits the articular osteopenia in rats with adjuvant-induced arthritis by suppressing the osteoclast differentiation induced by histamine.
    Journal of pharmacological sciences, 2003, Volume: 92, Issue:1

    Topics: Animals; Arthritis, Experimental; Bone Density; Bone Resorption; Cartilage, Articular; Cell Differen

2003